The House of Lords Science and Technology Committee has launched an inquiry into Life Sciences and the Industrial Strategy, and would like your views.
The Government set out in its Industrial Strategy Green Paper its intention to create a new Life Sciences strategy to make the UK the best place in the world to invest in life sciences. To tackle challenges like cancer and dementia it is important that the UK has a strong life sciences sector. But the sector faces a number of challenges and opportunities, including Brexit and making innovative new treatments available on the NHS.
This inquiry will investigate issues such as whether the Government has the necessary structures in place to support the life sciences sector; how the NHS can use procurement to stimulate innovation and the contents of the new life sciences industrial strategy, when published.
The Committee invites submissions, with practical examples where possible, on topics including those mentioned below.
- What can be learnt from the impact of the 2011 UK Life Sciences Strategy and how can the success of the new strategy be measured against its stated objectives?
- Can public procurement, in particular by the NHS, be an effective stimulus for innovation in the Life Sciences Sector?
- Who should take responsibility for the implementation of the Life Sciences Industrial Strategy and to whom should they be accountable?
- How should the regulatory framework be changed or improved after Brexit to support the sector?
- Should the Government appoint a dedicated Life Sciences Minister?
Please note that the Committee is interested in hearing views from both inside and outside of the life sciences sector.
The deadline for written submissions is Friday 15 September 2017.
For all queries, please email email@example.com or call 020 7219 4963.